speb/financial-data huggingface dataset:
DuPont ROE decomposition for CELH (annual period ending 2023-12-31)
ROE: 23.224636438249416%
Net margin: 17.20778383234169%
Asset turnover: 0.9556140824697794
Equity multiplier (leverage): 1.4123470961908384
EBIT margin: 20.209648759421373%
Interest burden factor: 1.0952936936395785
Tax burden factor: 0.7773839841781806
ROE archetype: High-Margin Compounder
DuPont ROE decomposition for CELH (annual period ending 2024-12-31)
ROE: 12.544526566779583%
Net margin: 10.701592617454615%
Asset turnover: 0.8207788810929268
Equity multiplier (leverage): 1.4281692820192438
EBIT margin: 11.487500276624154%
Interest burden factor: 1.2525043665878968
Tax burden factor: 0.7437785183286337
ROE archetype: Standard Business
DuPont ROE decomposition for CELH (annual period ending 2025-12-31)
ROE: 5.184957052074974%
Net margin: 4.293735580568122%
Asset turnover: 0.7304924909627558
Equity multiplier (leverage): 1.6530809132042155
EBIT margin: 18.627152801549258%
Interest burden factor: 0.2668663011207561
Tax burden factor: 0.8637639663128934
ROE archetype: Standard Business
DuPont ROE decomposition for CELLO.NS (annual period ending 2023-03-31)
ROE: 53.14254148714059%
Net margin: 15.9559903618364%
Asset turnover: 1.151310448536274
Equity multiplier (leverage): 2.892851290229425
EBIT margin: 21.608878771421853%
Interest burden factor: 0.9977885631126007
Tax burden factor: 0.7400362786807063
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for CELLO.NS (annual period ending 2024-03-31)
ROE: 37.205582942077115%
Net margin: 17.806828608282277%
Asset turnover: 1.1275894437801548
Equity multiplier (leverage): 1.8529791535895592
EBIT margin: 22.644984729766435%
Interest burden factor: 1.048663511859228
Tax burden factor: 0.7498568953695153
ROE archetype: Balanced Compounder
DuPont ROE decomposition for CELLO.NS (annual period ending 2025-03-31)
ROE: 19.118959134786927%
Net margin: 17.064645972831812%
Asset turnover: 0.9160323476191956
Equity multiplier (leverage): 1.2230836260683828
EBIT margin: 21.007328115399247%
Interest burden factor: 1.0946737519610712
Tax burden factor: 0.742064676996667
ROE archetype: High-Margin Compounder
DuPont ROE decomposition for CELLO.NS (annual period ending 2026-03-31)
ROE: 12.374769861577313%
Net margin: 14.266268148419172%
Asset turnover: 0.7853823972641276
Equity multiplier (leverage): 1.1044487931303577
EBIT margin: 16.976049356289575%
Interest burden factor: 1.1146443692838408
Tax burden factor: 0.7539411141283336
ROE archetype: Standard Business
DuPont ROE decomposition for CENER.BR (annual period ending 2022-12-31)
ROE: 17.68580042736294%
Net margin: 4.237002877964219%
Asset turnover: 0.8394479453949828
Equity multiplier (leverage): 4.972470216315898
EBIT margin: 7.065528384132487%
Interest burden factor: 0.6943278249218402
Tax burden factor: 0.863673399373901
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for CENER.BR (annual period ending 2023-12-31)
ROE: 19.929236345815948%
Net margin: 4.482212268303636%
Asset turnover: 0.9393556643281572
Equity multiplier (leverage): 4.7333452070927775
EBIT margin: 10.621094621136397%
Interest burden factor: 0.5515727490426997
Tax burden factor: 0.7651037679457198
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for CENER.BR (annual period ending 2024-12-31)
ROE: 24.393073475813488%
Net margin: 7.75997969326137%
Asset turnover: 0.8425808983546613
Equity multiplier (leverage): 3.730734384841778
EBIT margin: 13.05782299292827%
Interest burden factor: 0.7640561521376776
Tax burden factor: 0.777793896111142
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for CENER.BR (annual period ending 2025-12-31)
ROE: 25.604326900559894%
Net margin: 9.39151423627253%
Asset turnover: 0.8842099727490258
Equity multiplier (leverage): 3.083346505291454
EBIT margin: 14.4572630369356%
Interest burden factor: 0.8357970489118028
Tax burden factor: 0.7772284782573775
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for CENTRALBK.NS (annual period ending 2023-03-31)
ROE: 5.765572765177386%
Net margin: 10.660505511755192%
Asset turnover: 0.03890597082579363
Equity multiplier (leverage): 13.901075488732173
Tax burden factor: 1
ROE archetype: Standard Business
DuPont ROE decomposition for CENTRALBK.NS (annual period ending 2024-03-31)
ROE: 8.607212073949736%
Net margin: 15.127020310776764%
Asset turnover: 0.04108987386116225
Equity multiplier (leverage): 13.847593481903866
Tax burden factor: 1
ROE archetype: Standard Business
DuPont ROE decomposition for CENTRALBK.NS (annual period ending 2025-03-31)
ROE: 11.225599069147814%
Net margin: 20.066767853181297%
Asset turnover: 0.041819552454371016
Equity multiplier (leverage): 13.37681496633926
Tax burden factor: 1
ROE archetype: Standard Business
DuPont ROE decomposition for CENTRALBK.NS (annual period ending 2026-03-31)
ROE: 11.34521252495773%
Net margin: 21.92946045960948%
Asset turnover: 0.038222655216539246
Equity multiplier (leverage): 13.53517378098189
Tax burden factor: 1
ROE archetype: Standard Business
DuPont ROE decomposition for CERA.NS (quarterly period ending 2024-09-30)
Equity multiplier (leverage): 1.3944895772255808
ROE archetype: Standard Business
DuPont ROE decomposition for CERA.NS (quarterly period ending 2025-03-31)
ROE: 6.337855442971832%
Net margin: 14.807389126423768%
Asset turnover: 0.31396009656506535
Equity multiplier (leverage): 1.3632935686275904
EBIT margin: 16.506463270986767%
Interest burden factor: 1.1327484460656374
Tax burden factor: 0.7919376390333459
ROE archetype: Standard Business
DuPont ROE decomposition for CERA.NS (quarterly period ending 2025-06-30)
Net margin: 11.144555982617192%
EBIT margin: 10.796843012568116%
Interest burden factor: 1.3644020016278033
Tax burden factor: 0.7565256120424354
ROE archetype: Standard Business
DuPont ROE decomposition for CERA.NS (quarterly period ending 2025-09-30)
ROE: 4.133071723980536%
Net margin: 11.61018698214374%
Asset turnover: 0.2690181840236425
Equity multiplier (leverage): 1.323281043565662
EBIT margin: 11.745825945573483%
Interest burden factor: 1.260419756619333
Tax burden factor: 0.7842245815330475
ROE archetype: Low Return
DuPont ROE decomposition for CERA.NS (quarterly period ending 2025-12-31)
Net margin: 4.743344805520278%
EBIT margin: 8.26885280201469%
Interest burden factor: 0.7813085471224809
Tax burden factor: 0.734204191535035
ROE archetype: Standard Business
DuPont ROE decomposition for CERA.NS (quarterly period ending 2026-03-31)
ROE: 5.252589672823199%
Net margin: 12.012115887805177%
Asset turnover: 0.3287789023292735
Equity multiplier (leverage): 1.329995038505072
EBIT margin: 13.665741039595487%
Interest burden factor: 1.176455010217976
Tax burden factor: 0.7471555091389865
ROE archetype: Standard Business
DuPont ROE decomposition for CESC.NS (quarterly period ending 2024-09-30)
Equity multiplier (leverage): 3.0303725381634106
ROE archetype: Standard Business
DuPont ROE decomposition for CESC.NS (quarterly period ending 2024-12-31)
Net margin: 7.919123841617523%
EBIT margin: 21.707385565852288%
Interest burden factor: 0.46830530401034937
Tax burden factor: 0.7790055248618785
ROE archetype: Standard Business
DuPont ROE decomposition for CESC.NS (quarterly period ending 2025-03-31)
ROE: 3.0628892091080484%
Net margin: 9.956151663657465%
Asset turnover: 0.09460463218636503
Equity multiplier (leverage): 3.2518266246008722
EBIT margin: 28.836729429971626%
Interest burden factor: 0.41771019677996424
Tax burden factor: 0.8265524625267665
ROE archetype: Low Return
DuPont ROE decomposition for CESC.NS (quarterly period ending 2025-06-30)
Net margin: 7.766243752402922%
EBIT margin: 11.553248750480584%
Interest burden factor: 0.8452579034941764
Tax burden factor: 0.795275590551181
ROE archetype: Standard Business
DuPont ROE decomposition for CESC.NS (quarterly period ending 2025-12-31)
Net margin: 7.590511860174781%
EBIT margin: 24.444444444444443%
Interest burden factor: 0.39325842696629215
Tax burden factor: 0.7896103896103895
ROE archetype: Standard Business
DuPont ROE decomposition for CESC.NS (quarterly period ending 2026-03-31)
ROE: 3.480172871332172%
Net margin: 11.206054687499998%
Asset turnover: 0.08814288788465678
Equity multiplier (leverage): 3.5233907043748585
EBIT margin: 23.9013671875%
Interest burden factor: 0.6670071501532177
Tax burden factor: 0.7029096477794792
ROE archetype: Low Return
DuPont ROE decomposition for CEWATER.NS (quarterly period ending 2025-03-31)
ROE: 8.83140488124795%
Net margin: 22.769369012478684%
Asset turnover: 0.24389275425501206
Equity multiplier (leverage): 1.5903030870848363
EBIT margin: 26.804288067712434%
Interest burden factor: 0.9367914496332209
Tax burden factor: 0.9067839002616593
ROE archetype: Standard Business
DuPont ROE decomposition for CEWATER.NS (quarterly period ending 2025-06-30)
Net margin: 4.022775216813813%
EBIT margin: -4.33041643878428%
Tax burden factor: 0.7090721294542951
ROE archetype: Standard Business
DuPont ROE decomposition for CEWATER.NS (quarterly period ending 2025-09-30)
ROE: 0.8168558597721679%
Net margin: 3.597260603147903%
Asset turnover: 0.13636140222490428
Equity multiplier (leverage): 1.6652600715544634
EBIT margin: 3.163122271616805%
Interest burden factor: 1.2268928842745
Tax burden factor: 0.9269349845201238
ROE archetype: Low Return
DuPont ROE decomposition for CEWATER.NS (quarterly period ending 2025-12-31)
Net margin: -6.563917318884206%
EBIT margin: 0.03772827613887216%
Interest burden factor: -168.08510638297875
ROE archetype: Standard Business
DuPont ROE decomposition for CEWATER.NS (quarterly period ending 2026-03-31)
ROE: 2.476520728942138%
Net margin: 6.869891867756402%
Asset turnover: 0.21647006417071848
Equity multiplier (leverage): 1.6653066651736976
EBIT margin: 6.523363941682359%
Interest burden factor: 1.3231158395952682
Tax burden factor: 0.795940170940171
ROE archetype: Low Return
DuPont ROE decomposition for CFEB.BR (quarterly period ending 2024-12-31)
Equity multiplier (leverage): 4.446562405408134
ROE archetype: Standard Business
DuPont ROE decomposition for CFEB.BR (quarterly period ending 2025-06-30)
Equity multiplier (leverage): 4.518082206646415
ROE archetype: Standard Business
DuPont ROE decomposition for CFEB.BR (quarterly period ending 2025-12-31)
Equity multiplier (leverage): 4.299485596502136
ROE archetype: Standard Business
DuPont ROE decomposition for CFG (annual period ending 2022-12-31)
ROE: 8.750527648796961%
Net margin: 25.84465777334497%
Asset turnover: 0.035376411902987216
Equity multiplier (leverage): 9.57083157450401
Tax burden factor: 0.7807909604519774
ROE archetype: Standard Business
DuPont ROE decomposition for CFG (annual period ending 2023-12-31)
ROE: 6.695536309127248%
Net margin: 19.55252918287938%
Asset turnover: 0.036657254227240206
Equity multiplier (leverage): 9.341626415722851
Tax burden factor: 0.7921182266009852
ROE archetype: Standard Business
DuPont ROE decomposition for CFG (annual period ending 2024-12-31)
ROE: 6.2103876862293195%
Net margin: 19.323857087975412%
Asset turnover: 0.035537049046042525
Equity multiplier (leverage): 9.043645567536423
Tax burden factor: 0.7992584745762712
ROE archetype: Standard Business
DuPont ROE decomposition for CFG (annual period ending 2025-12-31)
ROE: 7.241304304838741%
Net margin: 22.202012853158728%
Asset turnover: 0.0371593612572994
Equity multiplier (leverage): 8.777204326590338
Tax burden factor: 0.7865120274914089
ROE archetype: Standard Business
DuPont ROE decomposition for CGF.AX (annual period ending 2022-06-30)
ROE: 6.361106235739538%
Net margin: 24.604790999903017%
Asset turnover: 0.0346877396956118
Equity multiplier (leverage): 7.45310031843141
EBIT margin: -49.69450101832994%
Tax burden factor: 0.7100475790652113
ROE archetype: Standard Business
DuPont ROE decomposition for CGF.AX (annual period ending 2023-06-30)
ROE: 6.91294121665941%
Net margin: 17.74253270797334%
Asset turnover: 0.052361157068406314
Equity multiplier (leverage): 7.44111496559117
EBIT margin: -54.00518390520859%
Tax burden factor: 0.7046568627450981
ROE archetype: Standard Business
DuPont ROE decomposition for CGF.AX (annual period ending 2024-06-30)
ROE: 3.2385853113598206%
Net margin: 6.547379032258065%
Asset turnover: 0.06186465889570498
Equity multiplier (leverage): 7.9954927875685184
EBIT margin: -71.14415322580645%
Tax burden factor: 0.6854881266490765
ROE archetype: Low Return
DuPont ROE decomposition for CGF.AX (annual period ending 2025-06-30)
ROE: 4.91350644479319%
Net margin: 8.355057351407718%
Asset turnover: 0.06668488312862896
Equity multiplier (leverage): 8.81890573170875
EBIT margin: -53.58446298227321%
Tax burden factor: 0.6985107155830004
ROE archetype: Low Return
DuPont ROE decomposition for CGNT (quarterly period ending 2025-01-31)
ROE: -0.09949194621907571%
Net margin: -0.22855933548489496%
Asset turnover: 0.1898376923385963
Equity multiplier (leverage): 2.2930129938324204
EBIT margin: 0.737527114967462%
Interest burden factor: -0.3945480631276901
ROE archetype: Low Return
DuPont ROE decomposition for CGNT (quarterly period ending 2025-04-30)
ROE: 0.06523910460368425%
Net margin: 0.14861640222715286%
Asset turnover: 0.19207940146659913
Equity multiplier (leverage): 2.2853906935074924
EBIT margin: 2.253317704190564%
Interest burden factor: 1.9874593590339062
Tax burden factor: 0.03318532367375555
ROE archetype: Low Return
DuPont ROE decomposition for CGNT (quarterly period ending 2025-07-31)
ROE: 1.2819001552010152%
Net margin: 2.80372873360475%
Asset turnover: 0.20597011990507444
Equity multiplier (leverage): 2.219800709333076
EBIT margin: 2.81500928081384%
Interest burden factor: 0.5056466302367941
Tax burden factor: 1.9697406340057637
ROE archetype: Low Return
DuPont ROE decomposition for CGNT (quarterly period ending 2025-10-31)
ROE: -1.5231975469702823%
Net margin: -3.356231015108499%
Asset turnover: 0.2047346431996688
Equity multiplier (leverage): 2.216731278294842
EBIT margin: 3.179535031467768%
Interest burden factor: 0.5248204807992507
Tax burden factor: -2.0113027959547884
ROE archetype: Low Return
DuPont ROE decomposition for CGNT (quarterly period ending 2026-01-31)
ROE: 2.2992695266261105%
Net margin: 4.817303891116508%
Asset turnover: 0.210252136694003
Equity multiplier (leverage): 2.2701022625124545
EBIT margin: 4.856836279437511%
Interest burden factor: 0.774031007751938
Tax burden factor: 1.2814221331997995
ROE archetype: Low Return
DuPont ROE decomposition for CGNT (quarterly period ending 2026-04-30)
ROE: -0.9116378363738733%
Net margin: -1.8967903387870404%
Asset turnover: 0.20593468668599976
Equity multiplier (leverage): 2.333853061070309
EBIT margin: 4.176540845924888%
Interest burden factor: 0.5848842487517022
Tax burden factor: -0.7764842840512224
ROE archetype: Low Return
DuPont ROE decomposition for CHAM.SW (quarterly period ending 2024-12-31)
Equity multiplier (leverage): 1.3608615007168086
ROE archetype: Standard Business
DuPont ROE decomposition for CHAM.SW (quarterly period ending 2025-06-30)
Equity multiplier (leverage): 1.5493629335968162
ROE archetype: Standard Business
DuPont ROE decomposition for CHAM.SW (quarterly period ending 2025-12-31)
Equity multiplier (leverage): 1.6622762336666874
ROE archetype: Standard Business
DuPont ROE decomposition for CHEMPLASTS.NS (annual period ending 2023-03-31)
ROE: 8.197647514608867%
Net margin: 3.087426766074986%
Asset turnover: 0.8454213546190786
Equity multiplier (leverage): 3.1406487091462822
EBIT margin: 7.971579866775559%
Interest burden factor: 0.43601281269066505
Tax burden factor: 0.8882863972946183
ROE archetype: Standard Business
DuPont ROE decomposition for CHEMPLASTS.NS (annual period ending 2024-03-31)
ROE: -8.830510209485599%
Net margin: -4.045720239326454%
Asset turnover: 0.6549146035441243
Equity multiplier (leverage): 3.33276947019803
EBIT margin: -2.3059303011499006%
ROE archetype: Low Return
DuPont ROE decomposition for CHEMPLASTS.NS (annual period ending 2025-03-31)
ROE: -5.788837796280041%
Net margin: -2.549707278078894%
Asset turnover: 0.68222107214045
Equity multiplier (leverage): 3.3279433703752264
EBIT margin: 1.2244879099146555%
Interest burden factor: -3.19
ROE archetype: Low Return
DuPont ROE decomposition for CHEMPLASTS.NS (annual period ending 2026-03-31)
ROE: -13.867530451444395%
Net margin: -6.637527036770008%
Asset turnover: 0.625174879761267
Equity multiplier (leverage): 3.341883498332405
EBIT margin: 0.5165446059272188%
Interest burden factor: -17.098714416896236
ROE archetype: Low Return
DuPont ROE decomposition for CHIB.L (quarterly period ending 2024-09-30)
Equity multiplier (leverage): 1.1394534616489516
ROE archetype: Standard Business
DuPont ROE decomposition for CHIB.L (quarterly period ending 2025-03-31)
Equity multiplier (leverage): 1.1424443879442203
ROE archetype: Standard Business
DuPont ROE decomposition for CHIB.L (quarterly period ending 2025-09-30)
Equity multiplier (leverage): 1.1470439806629185
ROE archetype: Standard Business
DuPont ROE decomposition for CHIB.L (quarterly period ending 2026-03-31)
Equity multiplier (leverage): 1.152152638427711
ROE archetype: Standard Business
DuPont ROE decomposition for CHKP (quarterly period ending 2025-03-31)
ROE: 6.945606694560668%
Net margin: 29.931012856694885%
Asset turnover: 0.11475557314813149
Equity multiplier (leverage): 2.0221575404766234
EBIT margin: 30.65224208215741%
Interest burden factor: 1.1396419437340153
Tax burden factor: 0.8568222621184919
ROE archetype: Standard Business
DuPont ROE decomposition for CHKP (quarterly period ending 2025-06-30)
ROE: 7.5673834137592575%
Net margin: 30.487071557426336%
Asset turnover: 0.12326806913531439
Equity multiplier (leverage): 2.0136288986651567
EBIT margin: 30.607336139506913%
Interest burden factor: 1.1399803536345776
Tax burden factor: 0.8737613097802671
ROE archetype: Standard Business
DuPont ROE decomposition for CHKP (quarterly period ending 2025-09-30)
ROE: 12.268066875473863%
Net margin: 52.944649446494466%
Asset turnover: 0.12042195936354959
Equity multiplier (leverage): 1.9241918389645527
EBIT margin: 29.387453874538743%
Interest burden factor: 1.1441486690105473
Tax burden factor: 1.574626865671642
ROE archetype: Standard Business
DuPont ROE decomposition for CHKP (quarterly period ending 2025-12-31)
ROE: 10.426402027774047%
Net margin: 40.87797019734193%
Asset turnover: 0.11216558708424308
Equity multiplier (leverage): 2.273974080760793
EBIT margin: 31.26594173714593%
Interest burden factor: 1.1266638042078145
Tax burden factor: 1.1604420731707317
ROE archetype: Standard Business
DuPont ROE decomposition for CHKP (quarterly period ending 2026-03-31)
ROE: 6.74853006411396%
Net margin: 28.6654697785757%
Asset turnover: 0.0869757398594246
Equity multiplier (leverage): 2.706773971847896
EBIT margin: 27.69299820466787%
Interest burden factor: 1.220421393841167
Tax burden factor: 0.8481629039397963
ROE archetype: Standard Business
DuPont ROE decomposition for CHMG (quarterly period ending 2025-03-31)
ROE: 2.63812602384519%
Net margin: 23.686487336794084%
Asset turnover: 0.009092063038017682
Equity multiplier (leverage): 12.24989706797018
Tax burden factor: 0.7835306361389359
ROE archetype: Low Return
DuPont ROE decomposition for CHMG (quarterly period ending 2025-06-30)
ROE: -2.7439603515861095%
Net margin: -64.81084939329051%
Asset turnover: 0.003471988045060436
Equity multiplier (leverage): 12.194160234160494
ROE archetype: Low Return
DuPont ROE decomposition for CHMG (quarterly period ending 2025-09-30)
ROE: 3.2448144184361425%
Net margin: 27.326927123518274%
Asset turnover: 0.01027694110888173
Equity multiplier (leverage): 11.55407538196946
Tax burden factor: 0.7740141054931956
ROE archetype: Low Return
DuPont ROE decomposition for CHMG (quarterly period ending 2025-12-31)
ROE: 3.13709333882648%
Net margin: 25.9693387636171%
Asset turnover: 0.011171345190719434
Equity multiplier (leverage): 10.813370345408256
Tax burden factor: 0.7134540161921222
ROE archetype: Low Return
DuPont ROE decomposition for CHMG (quarterly period ending 2026-03-31)
ROE: 3.5542212897816623%
Net margin: 31.109232330064255%
Asset turnover: 0.0108335713214081
Equity multiplier (leverage): 10.545896939560079
Tax burden factor: 0.7768769529600541
ROE archetype: Low Return
DuPont ROE decomposition for CHOLAHLDNG.NS (annual period ending 2023-03-31)
ROE: 11.399680603477655%
Net margin: 14.496520880393202%
Asset turnover: 0.1479119452082896
Equity multiplier (leverage): 5.316497933984893
EBIT margin: 18.10060604684712%
Interest burden factor: 1.0901503360755271
Tax burden factor: 0.7346564166928146
ROE archetype: Standard Business
DuPont ROE decomposition for CHOLAHLDNG.NS (annual period ending 2024-03-31)
ROE: 16.330547024825314%
Net margin: 14.117238160567746%
Asset turnover: 0.1759661607749214
Equity multiplier (leverage): 6.57388091205519
EBIT margin: 17.50590912973835%
Interest burden factor: 1.0890061237654036
Tax burden factor: 0.740516516886129
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for CHOLAHLDNG.NS (annual period ending 2025-03-31)
ROE: 19.09566374304817%
Net margin: 13.605886618185616%
Asset turnover: 0.1715705955587176
Equity multiplier (leverage): 8.180221288359228
EBIT margin: 16.79537089609949%
Interest burden factor: 1.0937549136899674
Tax burden factor: 0.7406571701804499
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for CHOLAHLDNG.NS (annual period ending 2026-03-31)
ROE: 17.246888991602745%
Net margin: 13.479402502392915%
Asset turnover: 0.15769176755886166
Equity multiplier (leverage): 8.113927168378046
EBIT margin: 16.076406167637963%
Interest burden factor: 1.119832222048982
Tax burden factor: 0.7487359949330596
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for CHR.TO (quarterly period ending 2024-12-31)
ROE: -1.2884121043543486%
Net margin: -1.8677351304667922%
Asset turnover: 0.219746885537232
Equity multiplier (leverage): 3.139184057755866
EBIT margin: 3.7671843807959675%
Interest burden factor: -3.549684305472039
ROE archetype: Low Return
DuPont ROE decomposition for CHR.TO (quarterly period ending 2025-03-31)
ROE: 3.6828468388557556%
Net margin: 5.438501245228062%
Asset turnover: 0.23024861604396912
Equity multiplier (leverage): 2.941083787537494
EBIT margin: 8.534192784858487%
Interest burden factor: 0.8791316055200269
Tax burden factor: 0.724874612351162
ROE archetype: Low Return
DuPont ROE decomposition for CHR.TO (quarterly period ending 2025-06-30)
ROE: 6.2875243069336335%
Net margin: 9.99254494596626%
Asset turnover: 0.2394948107145255
Equity multiplier (leverage): 2.6272866491688758
EBIT margin: 7.415622342981775%
Interest burden factor: 1.3639498172150215
Tax burden factor: 0.9879389638473486
ROE archetype: Standard Business
DuPont ROE decomposition for CHR.TO (quarterly period ending 2025-12-31)
ROE: 3.2890474699559107%
Net margin: 5.216590149598675%
Asset turnover: 0.24433666095359902
Equity multiplier (leverage): 2.5804460880164304
EBIT margin: 6.551110278272275%
Interest burden factor: 1.1062643020594967
Tax burden factor: 0.7198017668605903
ROE archetype: Low Return
DuPont ROE decomposition for CHR.TO (quarterly period ending 2026-03-31)
ROE: 1.380265271973759%
Net margin: 2.1513471655440286%
Asset turnover: 0.2460501245770134
Equity multiplier (leverage): 2.607524953095852
EBIT margin: 5.578568267859777%
Interest burden factor: 0.6042194557673239
Tax burden factor: 0.6382532591849759
ROE archetype: Low Return
DuPont ROE decomposition for CIE.MC (annual period ending 2022-12-31)
ROE: 22.7441748872993%
Net margin: 8.915215575654287%
Asset turnover: 0.6801954216501545
Equity multiplier (leverage): 3.750633536459334
EBIT margin: 11.638052980691427%
Interest burden factor: 0.9429868446676919
Tax burden factor: 0.8123550510481427
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for CIE.MC (annual period ending 2023-12-31)
ROE: 23.288502588281247%
Net margin: 9.12213450304952%
Asset turnover: 0.7152081837899833
Equity multiplier (leverage): 3.5695430024457555
EBIT margin: 13.326803854749578%
Interest burden factor: 0.8521240467563184
Tax burden factor: 0.8032812771048968
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for CIE.MC (annual period ending 2024-12-31)
ROE: 19.69416386280972%
Net margin: 9.16429641805252%
Asset turnover: 0.6596616712976884
Equity multiplier (leverage): 3.257745611293989
EBIT margin: 13.593700882830815%
Interest burden factor: 0.8592924035914753
Tax burden factor: 0.784549673497885
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for CIE.MC (annual period ending 2025-12-31)
ROE: 20.861086773771596%
Net margin: 9.33447154590674%
Asset turnover: 0.7225507828194667
Equity multiplier (leverage): 3.092992148043016
EBIT margin: 13.715040448399836%
Interest burden factor: 0.9029152145241269
Tax burden factor: 0.7537818434791125
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for CIF (annual period ending 2022-11-30)
ROE: -16.199806695493074%
Asset turnover: -0.10845867933367083
Equity multiplier (leverage): 1.456169040022698
ROE archetype: Low Return
DuPont ROE decomposition for CIF (annual period ending 2023-11-30)
ROE: 8.24525754299782%
Net margin: 92.53844653318261%
Asset turnover: 0.061025690020817196
Equity multiplier (leverage): 1.4600553573739314
Tax burden factor: 1
ROE archetype: Standard Business
DuPont ROE decomposition for CIF (annual period ending 2024-11-30)
ROE: 12.424130465284936%
Net margin: 94.67438802138437%
Asset turnover: 0.09000579154711955
Equity multiplier (leverage): 1.4580185221117656
Tax burden factor: 1
ROE archetype: Standard Business
DuPont ROE decomposition for CIF (annual period ending 2025-11-30)
ROE: 7.746391865724646%
Net margin: 93.04879080221487%
Asset turnover: 0.05709036250483168
Equity multiplier (leverage): 1.4582296634539347
Tax burden factor: 1
ROE archetype: Standard Business
DuPont ROE decomposition for CIS.DE (quarterly period ending 2025-04-30)
ROE: 5.422880156743224%
Net margin: 17.605484486536152%
Asset turnover: 0.11812292331068107
Equity multiplier (leverage): 2.607641232175901
EBIT margin: 22.87087426673263%
Interest burden factor: 0.9106922126081582
Tax burden factor: 0.8452663725822871
ROE archetype: Standard Business
DuPont ROE decomposition for CIS.DE (quarterly period ending 2025-07-31)
ROE: 5.49699282157408%
Net margin: 17.378859129012472%
Asset turnover: 0.12122789406501344
Equity multiplier (leverage): 2.609163810386083
EBIT margin: 21.277175765010565%
Interest burden factor: 0.9606021780909674
Tax burden factor: 0.8502834278092698
ROE archetype: Standard Business
DuPont ROE decomposition for CIS.DE (quarterly period ending 2025-10-31)
ROE: 6.103546886337445%
Net margin: 19.216555801921658%
Asset turnover: 0.12229603973820118
Equity multiplier (leverage): 2.597133893892185
EBIT margin: 23.58395484781294%
Interest burden factor: 0.9660968660968661
Tax burden factor: 0.8434090238867591
ROE archetype: Standard Business
DuPont ROE decomposition for CIS.DE (quarterly period ending 2026-01-31)
ROE: 6.71275741046133%
Net margin: 20.68538667014138%
Asset turnover: 0.12556805864042245
Equity multiplier (leverage): 2.584390460484587
EBIT margin: 24.868069581080203%
Interest burden factor: 0.9552004191773644
Tax burden factor: 0.8708173340647285
ROE archetype: Standard Business
DuPont ROE decomposition for CIS.DE (quarterly period ending 2026-04-30)
ROE: 6.984593721527375%
Net margin: 21.29284767375797%
Asset turnover: 0.12727937424924773
Equity multiplier (leverage): 2.577207404953201
EBIT margin: 24.992109084022474%
Interest burden factor: 1.0202071230108614
Tax burden factor: 0.8351076999257242
ROE archetype: Standard Business
DuPont ROE decomposition for CKT.L (annual period ending 2023-01-31)
ROE: -65.07936507936509%
Net margin: -119.41747572815535%
Asset turnover: 0.37591240875912413
Equity multiplier (leverage): 1.44973544973545
EBIT margin: -78.64077669902913%
ROE archetype: Low Return
DuPont ROE decomposition for CKT.L (annual period ending 2024-01-31)
ROE: -27.245206861755804%
Net margin: -37.5%
Asset turnover: 0.4817008201798944
Equity multiplier (leverage): 1.5082782075718506
EBIT margin: -41.66666666666667%
ROE archetype: Low Return
DuPont ROE decomposition for CKT.L (annual period ending 2025-01-31)
ROE: -27.815541102254393%
Net margin: -25.53191489361702%
Asset turnover: 0.6513844624426186
Equity multiplier (leverage): 1.6725023228519733
EBIT margin: -26.95035460992908%
ROE archetype: Low Return
DuPont ROE decomposition for CKT.L (annual period ending 2026-01-31)
ROE: -30.45133224578575%
Net margin: -20.43795620437956%
Asset turnover: 0.7986009909647335
Equity multiplier (leverage): 1.8656878738444806
EBIT margin: -10.94890510948905%
ROE archetype: Low Return
DuPont ROE decomposition for CLBX.L (annual period ending 2021-12-31)
ROE: -37.22291098437888%
Net margin: -1481.934846989141%
Asset turnover: 0.02140970094050513
Equity multiplier (leverage): 1.1731961319117281
EBIT margin: -1710.4639684106612%
ROE archetype: Low Return
DuPont ROE decomposition for CLBX.L (annual period ending 2022-12-31)
ROE: -50.847616591244815%
Net margin: -2083.1892411143135%
Asset turnover: 0.020225859899017734
Equity multiplier (leverage): 1.2067988349905863
EBIT margin: -2508.0691642651295%
ROE archetype: Low Return
DuPont ROE decomposition for CLBX.L (annual period ending 2023-12-31)
ROE: -65.92954624994624%
Net margin: -920.9515096065875%
Asset turnover: 0.055589657770865074
Equity multiplier (leverage): 1.2878026733142445
EBIT margin: -935.8645928636779%
ROE archetype: Low Return
DuPont ROE decomposition for CLBX.L (annual period ending 2024-12-31)
ROE: -68.2739365830498%
Net margin: -497.03004891684134%
Asset turnover: 0.10035815884426859
Equity multiplier (leverage): 1.3687357588596945
EBIT margin: -540.7407407407408%
ROE archetype: Low Return
DuPont ROE decomposition for CLBX.L (annual period ending 2025-12-31)
ROE: -160.87293087613654%
Net margin: -1444.041450777202%
Asset turnover: 0.07478001198362147
Equity multiplier (leverage): 1.489765058645147
EBIT margin: -1140.044411547002%
ROE archetype: Low Return
DuPont ROE decomposition for CLDN.L (annual period ending 2022-03-31)
ROE: 21.964279297085564%
Net margin: 97.69820971867009%
Asset turnover: 0.22226959425850917
Equity multiplier (leverage): 1.0114636863477917
Tax burden factor: 1.0324324324324325
ROE archetype: High-Margin Compounder
DuPont ROE decomposition for CLDN.L (annual period ending 2023-03-31)
ROE: 4.958558071548079%
Net margin: 79.38888888888889%
Asset turnover: 0.05906314964607444
Equity multiplier (leverage): 1.0574968376659384
Tax burden factor: 0.9577747989276139
ROE archetype: Low Return
DuPont ROE decomposition for CLDN.L (annual period ending 2024-03-31)
ROE: 7.158143864043918%
Net margin: 87.16852010265183%
Asset turnover: 0.07770190635914638
Equity multiplier (leverage): 1.0568395943640425
Tax burden factor: 1.0119165839126116
ROE archetype: Standard Business
DuPont ROE decomposition for CLDN.L (annual period ending 2025-03-31)
ROE: 2.2707640058313916%
Net margin: 63.49663784822286%
Asset turnover: 0.035402272032144834
Equity multiplier (leverage): 1.0101599284230345
Tax burden factor: 0.9895209580838323
ROE archetype: Low Return
DuPont ROE decomposition for CLDN.L (annual period ending 2026-03-31)
ROE: 4.603707234927749%
Net margin: 84.2367601246106%
Asset turnover: 0.054267116195782276
Equity multiplier (leverage): 1.0070923553978492
Tax burden factor: 0.9933872152828803
ROE archetype: Low Return
DuPont ROE decomposition for CLIP.V (annual period ending 2022-12-31)
ROE: -588.7775290536614%
Net margin: -43832.123379203236%
Asset turnover: 0.0028086268779718726
Equity multiplier (leverage): 4.782606712834261
EBIT margin: -28801.99371546213%
ROE archetype: Low Return
DuPont ROE decomposition for CLIP.V (annual period ending 2023-12-31)
ROE: -654.0810801055608%
Net margin: -1612.0887183151965%
Asset turnover: 0.04933244725008517
Equity multiplier (leverage): 8.224509148987295
EBIT margin: -1438.8009392319686%
ROE archetype: Low Return
DuPont ROE decomposition for CLIP.V (annual period ending 2024-12-31)
Net margin: -395.6591700493453%
Asset turnover: 0.19186131933369813
EBIT margin: -329.544055460535%
ROE archetype: Standard Business
DuPont ROE decomposition for CLIP.V (annual period ending 2025-12-31)
Net margin: -157.9667802290097%
Asset turnover: 0.6049085012015497
EBIT margin: -119.61852732947888%
ROE archetype: Standard Business
DuPont ROE decomposition for CLMB (quarterly period ending 2025-03-31)
ROE: 3.8554115997237166%
Net margin: 2.668714322969488%
Asset turnover: 0.3730384566535064
Equity multiplier (leverage): 3.872710718546581
EBIT margin: 3.552490510272087%
Interest burden factor: 0.866231647634584
Tax burden factor: 0.867231638418079
ROE archetype: Low Return
DuPont ROE decomposition for CLMB (quarterly period ending 2025-06-30)
ROE: 5.9462663963214455%
Net margin: 3.7467667813465257%
Asset turnover: 0.4028712200155803
Equity multiplier (leverage): 3.9393217788981274
EBIT margin: 5.003013485346928%
Interest burden factor: 0.9715146191492031
Tax burden factor: 0.7708602428313097
ROE archetype: Standard Business
DuPont ROE decomposition for CLMB (quarterly period ending 2025-09-30)
ROE: 4.379800316173831%
Net margin: 2.910569408031337%
Asset turnover: 0.4049865584312899
Equity multiplier (leverage): 3.7156580659301714
EBIT margin: 4.667695530639692%
Interest burden factor: 0.8369406453326251
Tax burden factor: 0.7450420434713628
ROE archetype: Low Return
DuPont ROE decomposition for CLMB (quarterly period ending 2025-12-31)
ROE: 6.184882284439052%
Net margin: 3.6028600022698427%
Asset turnover: 0.46356675164170824
Equity multiplier (leverage): 3.7031539888682747
EBIT margin: 4.947226148592181%
Interest burden factor: 1.0038581856100104
Tax burden factor: 0.725459644749143
ROE archetype: Standard Business
DuPont ROE decomposition for CLMB (quarterly period ending 2026-03-31)
ROE: 2.8373381444965937%
Net margin: 1.8280914155371322%
Asset turnover: 0.3968703179623772
Equity multiplier (leverage): 3.910790650570829
EBIT margin: 2.294709830240821%
Interest burden factor: 0.996415770609319
Tax burden factor: 0.7995203836930456
ROE archetype: Low Return
DuPont ROE decomposition for CLN.SW (annual period ending 2022-12-31)
ROE: 4.615996816553919%
Net margin: 2.23162754905733%
Asset turnover: 0.8400129282482224
Equity multiplier (leverage): 2.462395543175487
EBIT margin: 0.5963832243170449%
Interest burden factor: 0.19354838709677422
Tax burden factor: 19.333333333333332
ROE archetype: Low Return
DuPont ROE decomposition for CLN.SW (annual period ending 2023-12-31)
ROE: 8.00093282675658%
Net margin: 4.0895590587160155%
Asset turnover: 0.7960415768852129
Equity multiplier (leverage): 2.4576972782835984
EBIT margin: 5.483207676490747%
Interest burden factor: 0.9083333333333333
Tax burden factor: 0.8211009174311926
ROE archetype: Standard Business
DuPont ROE decomposition for CLN.SW (annual period ending 2024-12-31)
ROE: 11.56137556774612%
Net margin: 6.74373795761079%
Asset turnover: 0.6924080261582718
Equity multiplier (leverage): 2.475977703061405
EBIT margin: 9.272639691714838%
Interest burden factor: 0.961038961038961
Tax burden factor: 0.7567567567567568
ROE archetype: Standard Business
DuPont ROE decomposition for CLN.SW (annual period ending 2025-12-31)
ROE: -1.8706655310865068%
Net margin: -1.0472541507024264%
Asset turnover: 0.6886906960789488
Equity multiplier (leverage): 2.5937005718457233
EBIT margin: 7.943805874840357%
Interest burden factor: 0.14790996784565916
Tax burden factor: -0.891304347826087
ROE archetype: Low Return
DuPont ROE decomposition for CLNX.MC (annual period ending 2022-12-31)
ROE: -1.9556927857584894%
Net margin: -9.146682604035517%
Asset turnover: 0.07381764503085159
Equity multiplier (leverage): 2.8965220482705045
EBIT margin: 7.091636483888816%
Interest burden factor: -2.1834436165963287
ROE archetype: Low Return
DuPont ROE decomposition for CLNX.MC (annual period ending 2023-12-31)
ROE: -2.002166697538683%
Net margin: -7.813198264177687%
Asset turnover: 0.08796620523878461
Equity multiplier (leverage): 2.9131009247020963
EBIT margin: 8.083303277852492%
Interest burden factor: -1.4192490934811948
ROE archetype: Low Return
DuPont ROE decomposition for CLNX.MC (annual period ending 2024-12-31)
ROE: -0.17815880765958478%
Net margin: -0.6889824959676479%
Asset turnover: 0.0894635668299544
Equity multiplier (leverage): 2.8903663991349435
EBIT margin: 14.342348849750813%
Interest burden factor: -1.2007167292205911
ROE archetype: Low Return
DuPont ROE decomposition for CLNX.MC (annual period ending 2025-12-31)
ROE: -2.6228708901789695%
Net margin: -8.559514612802065%
Asset turnover: 0.10207714093267278
Equity multiplier (leverage): 3.001921131634195
EBIT margin: 13.152504807345755%
Interest burden factor: -0.8336737913739558
ROE archetype: Low Return
DuPont ROE decomposition for CLSK (quarterly period ending 2025-03-31)
ROE: -7.341584805217269%
Net margin: -76.38020604032755%
Asset turnover: 0.06838996491529162
Equity multiplier (leverage): 1.4054539270485815
EBIT margin: -6.926895306859206%
ROE archetype: Low Return
DuPont ROE decomposition for CLSK (quarterly period ending 2025-06-30)
ROE: 12.750351156034645%
Net margin: 129.57350838686293%
Asset turnover: 0.06898780391452061
Equity multiplier (leverage): 1.426374635623755
EBIT margin: -11.242222266970057%
Tax burden factor: 0.9342751463718298
ROE archetype: Standard Business
DuPont ROE decomposition for CLSK (quarterly period ending 2025-09-30)
ROE: -0.042804108731691125%
Net margin: -0.4135889685761809%
Asset turnover: 0.07116501480880917
Equity multiplier (leverage): 1.4542864844291379
EBIT margin: -28.21034464256971%
Tax burden factor: -0.06652283351312477
ROE archetype: Low Return
DuPont ROE decomposition for CLSK (quarterly period ending 2025-12-31)
ROE: -21.29155055837395%
Net margin: -209.02472679103653%
Asset turnover: 0.05566368296463338
Equity multiplier (leverage): 1.8299435287119774
EBIT margin: -37.83364609780329%
ROE archetype: Low Return
DuPont ROE decomposition for CLSK (quarterly period ending 2026-03-31)
ROE: -31.94903260238066%
Net margin: -277.36129845756847%
Asset turnover: 0.0437227550130776
Equity multiplier (leverage): 2.634537175901531
EBIT margin: -83.26051257990734%
ROE archetype: Low Return
DuPont ROE decomposition for CLYM (quarterly period ending 2025-03-31)
ROE: -10.745921348605114%
Asset turnover: 0
Equity multiplier (leverage): 1.0380329394730718
ROE archetype: Low Return
DuPont ROE decomposition for CLYM (quarterly period ending 2025-06-30)
ROE: -4.5712899150465915%
Asset turnover: 0
Equity multiplier (leverage): 1.036864135208058
ROE archetype: Low Return
DuPont ROE decomposition for CLYM (quarterly period ending 2025-09-30)
ROE: -7.10538720445906%
Asset turnover: 0
Equity multiplier (leverage): 1.0328668263651324
ROE archetype: Low Return
DuPont ROE decomposition for CLYM (quarterly period ending 2025-12-31)
ROE: -10.380528508525%
Asset turnover: 0
Equity multiplier (leverage): 1.0372468723887187
ROE archetype: Low Return
DuPont ROE decomposition for CLYM (quarterly period ending 2026-03-31)
ROE: -8.894218304381644%
Asset turnover: 0
Equity multiplier (leverage): 1.0374513870884108
ROE archetype: Low Return
DuPont ROE decomposition for CMBN.SW (annual period ending 2022-12-31)
ROE: 13.284751032053494%
Net margin: 33.27070956787637%
Asset turnover: 0.06674550677615264
Equity multiplier (leverage): 5.982315613374442
Tax burden factor: 0.8043987475590229
ROE archetype: Standard Business
DuPont ROE decomposition for CMBN.SW (annual period ending 2023-12-31)
ROE: 13.096721557939405%
Net margin: 30.645198822539292%
Asset turnover: 0.068533768079341
Equity multiplier (leverage): 6.235848283787842
Tax burden factor: 0.8055797688774704
ROE archetype: Standard Business
DuPont ROE decomposition for CMBN.SW (annual period ending 2024-12-31)
ROE: 12.986972404484238%
Net margin: 30.955720187336272%
Asset turnover: 0.06626131592823728
Equity multiplier (leverage): 6.331504921319532
Tax burden factor: 0.804590591223953
ROE archetype: Standard Business
DuPont ROE decomposition for CMBN.SW (annual period ending 2025-12-31)
ROE: 14.51957446540319%
Net margin: 33.11877179813018%
Asset turnover: 0.07268104264746249
Equity multiplier (leverage): 6.031960887801555
Tax burden factor: 0.8038489775453928
ROE archetype: Standard Business
DuPont ROE decomposition for CMBT (annual period ending 2022-12-31)
ROE: 9.351473338655097%
Net margin: 23.78125332731151%
Asset turnover: 0.21533214430674366
Equity multiplier (leverage): 1.8261499495045932
EBIT margin: 23.22080243930691%
Interest burden factor: 1.0382644449035328
Tax burden factor: 0.9863919827230594
ROE archetype: Standard Business
DuPont ROE decomposition for CMBT (annual period ending 2023-12-31)
ROE: 38.664232217860366%
Net margin: 69.4687266977404%
Asset turnover: 0.3421662110494588
Equity multiplier (leverage): 1.6266081018720127
EBIT margin: 48.35518938538304%
Interest burden factor: 1.4466955100728676
Tax burden factor: 0.9930454286626945
ROE archetype: High-Margin Compounder
DuPont ROE decomposition for CMBT (annual period ending 2024-12-31)
ROE: 46.98478645726438%
Net margin: 92.6171448748519%
Asset turnover: 0.24899666034539514
Equity multiplier (leverage): 2.037381443979792
EBIT margin: 39.27504078719824%
Interest burden factor: 2.3632941762663764
Tax burden factor: 0.9978309243951682
ROE archetype: Balanced Compounder
DuPont ROE decomposition for CMBT (annual period ending 2025-12-31)
ROE: 8.735796233975805%
Net margin: 9.645155094593296%
Asset turnover: 0.28088284120636026
Equity multiplier (leverage): 3.224542240119986
EBIT margin: 22.204215883991164%
Interest burden factor: 0.4036519435584148
Tax burden factor: 1.0761349253651382
ROE archetype: Standard Business
DuPont ROE decomposition for CMCM (annual period ending 2022-12-31)
ROE: -16.5381768662961%
Net margin: -58.081070870274395%
Asset turnover: 0.17201672017790337
Equity multiplier (leverage): 1.6553214939773626
EBIT margin: -25.517438743261252%
ROE archetype: Low Return
DuPont ROE decomposition for CMCM (annual period ending 2023-12-31)
ROE: -20.364985754749636%
Net margin: -88.70296324288314%
Asset turnover: 0.12303233743176219
Equity multiplier (leverage): 1.8660647422946417
EBIT margin: -31.342204590569423%
ROE archetype: Low Return
DuPont ROE decomposition for CMCM (annual period ending 2024-12-31)
ROE: -24.36172575131905%
Net margin: -74.55733649614503%
Asset turnover: 0.14296165117364182
Equity multiplier (leverage): 2.2855888544506673
EBIT margin: -35.242670196324845%
ROE archetype: Low Return
DuPont ROE decomposition for CMCM (annual period ending 2025-12-31)
ROE: -11.54185335282577%
Net margin: -20.440108340779734%
Asset turnover: 0.2309671948189435
Equity multiplier (leverage): 2.4447928055941053
EBIT margin: -11.984937989158968%
ROE archetype: Low Return
DuPont ROE decomposition for CMCSA (annual period ending 2022-12-31)
ROE: 6.5457470928106485%
Net margin: 4.422410172366936%
Asset turnover: 0.4719735691380818
Equity multiplier (leverage): 3.136046710061191
EBIT margin: 18.631770528795077%
Interest burden factor: 0.41036067892503536
Tax burden factor: 0.5784144765187419
ROE archetype: Standard Business
DuPont ROE decomposition for CMCSA (annual period ending 2023-12-31)
ROE: 18.595208603969667%
Net margin: 12.6575198236436%
Asset turnover: 0.46571637622920364
Equity multiplier (leverage): 3.154502885109211
EBIT margin: 19.176290593228703%
Interest burden factor: 0.8783940290824862
Tax burden factor: 0.7514405703682
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for CMCSA (annual period ending 2024-12-31)
ROE: 19.078478387661203%
Net margin: 13.08645367773638%
Asset turnover: 0.46601082441028807
Equity multiplier (leverage): 3.128425071137792
EBIT margin: 18.82955766946036%
Interest burden factor: 0.801485106017684
Tax burden factor: 0.867134365126118
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for CMCSA (annual period ending 2025-12-31)
ROE: 21.77838279335693%
Net margin: 16.165617143734792%
Asset turnover: 0.4591587144283482
Equity multiplier (leverage): 2.9340702423087395
EBIT margin: 16.708836201670074%
Interest burden factor: 1.2465408805031446
Tax burden factor: 0.7761390980361716
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for CMCT (annual period ending 2022-12-31)
ROE: 1.5738755195510021%
Net margin: 5.833807626636312%
Asset turnover: 0.14763679141410044
Equity multiplier (leverage): 1.8273581658856854
EBIT margin: 16.42592192805134%
Interest burden factor: 0.4227253718860147
Tax burden factor: 0.8401639344262295
ROE archetype: Low Return
DuPont ROE decomposition for CMCT (annual period ending 2023-12-31)
ROE: -12.852237047365206%
Net margin: -40.65555350584447%
Asset turnover: 0.15082127265645157
Equity multiplier (leverage): 2.0960239841272155
EBIT margin: -9.547367891462208%
ROE archetype: Low Return
DuPont ROE decomposition for CMCT (annual period ending 2024-12-31)
ROE: -7.153695768308347%
Net margin: -20.218934721151374%
Asset turnover: 0.1398418086710412
Equity multiplier (leverage): 2.530085304447652
EBIT margin: 12.46787458236957%
Interest burden factor: -1.607317701623293
ROE archetype: Low Return
DuPont ROE decomposition for CMCT (annual period ending 2025-12-31)
ROE: -13.14721428186182%
Net margin: -33.42961712194328%
Asset turnover: 0.13343191848769
Equity multiplier (leverage): 2.947423952321881
EBIT margin: 8.354404340484619%
Interest burden factor: -4.009233610341644
ROE archetype: Low Return
DuPont ROE decomposition for CME (annual period ending 2022-12-31)
ROE: 10.01164490842191%
Net margin: 53.61198549627445%
Asset turnover: 0.02881802685449233
Equity multiplier (leverage): 6.480064140006771
EBIT margin: 60.084870701677495%
Interest burden factor: 1.1572996452137008
Tax burden factor: 0.7709938973727187
ROE archetype: Standard Business
DuPont ROE decomposition for CME (annual period ending 2023-12-31)
ROE: 12.034332650708922%
Net margin: 57.82860420513004%
Asset turnover: 0.036717565843035024
Equity multiplier (leverage): 5.667681277813214
EBIT margin: 61.5838247683235%
Interest burden factor: 1.208953051779841
Tax burden factor: 0.7767238058551618
ROE archetype: Standard Business
DuPont ROE decomposition for CME (annual period ending 2024-12-31)
ROE: 13.248711127143736%
Net margin: 57.5161906004796%
Asset turnover: 0.045892037187665054
Equity multiplier (leverage): 5.019334971667343
EBIT margin: 64.13435343632241%
Interest burden factor: 1.1551316291491798
Tax burden factor: 0.7763685207204827
ROE archetype: Standard Business
DuPont ROE decomposition for CME (annual period ending 2025-12-31)
ROE: 14.75031286731347%
Net margin: 62.4513081618256%
Asset turnover: 0.03882797929682569
Equity multiplier (leverage): 6.082959190511291
EBIT margin: 64.86366285311168%
Interest burden factor: 1.2603144579737557
Tax burden factor: 0.7639433449019791
ROE archetype: Standard Business
DuPont ROE decomposition for CMG (quarterly period ending 2025-03-31)
ROE: 11.074568188120331%
Net margin: 13.445738514141189%
Asset turnover: 0.31791498407690144
Equity multiplier (leverage): 2.590783620825971
EBIT margin: 17.168158767245874%
Interest burden factor: 1.0159533089695074
Tax burden factor: 0.7708807325180508
ROE archetype: Standard Business
DuPont ROE decomposition for CMG (quarterly period ending 2025-06-30)
ROE: 12.426922267589125%
Net margin: 14.236730318310448%
Asset turnover: 0.3345614301796636
Equity multiplier (leverage): 2.609020258675405
EBIT margin: 18.77441124922594%
Interest burden factor: 1.0039608160880769
Tax burden factor: 0.7553133637679854
ROE archetype: Standard Business
DuPont ROE decomposition for CMG (quarterly period ending 2025-09-30)
ROE: 11.32151502074138%
Net margin: 12.722161625121029%
Asset turnover: 0.32381024872346736
Equity multiplier (leverage): 2.748229823469011
EBIT margin: 16.59151960216338%
Interest burden factor: 0.9972788405773835
Tax burden factor: 0.768879248069768
ROE archetype: Standard Business
DuPont ROE decomposition for CMG (quarterly period ending 2025-12-31)
ROE: 10.935481445928051%
Net margin: 11.092032172832612%
Asset turnover: 0.32648819550087027
Equity multiplier (leverage): 3.019668745440892
EBIT margin: 14.939747163660533%
Interest burden factor: 0.9728848695059106
Tax burden factor: 0.76314387641447
ROE archetype: Standard Business
DuPont ROE decomposition for CMG (quarterly period ending 2026-03-31)
ROE: 11.56204696155695%
Net margin: 9.805708231414508%
Asset turnover: 0.3470373502268545
Equity multiplier (leverage): 3.397657076553546
EBIT margin: 13.552143905820852%
Interest burden factor: 0.9696121837987398
Tax burden factor: 0.7462303323024605
ROE archetype: Standard Business
DuPont ROE decomposition for CMG.AX (annual period ending 2023-06-30)
ROE: -42.261193847595194%
Equity multiplier (leverage): 1.0431070273979335
ROE archetype: Low Return